The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Abstract
Hallucinations, mainly of a visual nature, are considered to affect about one-quarter of patients with Parkinson's disease. They are commonly viewed as a side-effect of antiparkinsonian treatment, but other factors may be involved. The aim of this study was to determine the phenomenology, prevalence and risk factors of hallucinations in Parkinson's disease. Two-hundred and sixteen consecutive patients fulfilling clinical criteria for Parkinson's disease were studied. Demographic and clinical variables were recorded, including motor and cognitive status, depressive symptoms and sleep-wake disturbances. Patients with and without hallucinations were compared using non-parametric tests, and logistic regression was applied to significant data. Hallucinations had been present during the previous 3 months in 39.8% of the patients, and fell into three categories: minor forms, consisting of a sensation of a presence (person), a sideways passage (commonly of an animal) or illusions were present in 25.5% of the patients (an isolated occurrence in 14.3%), formed visual hallucinations were present in 22.2% (isolated in 9.3%) and auditory hallucinations were present in 9.7% (isolated in 2.3%). Patients with minor hallucinations had a higher depression score than non-hallucinators but did not differ in other respects. Logistic regression analysis identified three factors independently predictive of formed visual hallucinations: severe cognitive disorders, daytime somnolence and a long duration of Parkinson's disease. These findings indicate that, when minor hallucinations are included, the total prevalence is much higher than previously reported. A simple side-effect of dopaminergic treatment is not sufficient to explain the occurrence of all visual hallucinations. The main risk factor in treated patients is cognitive impairment, although sleep-wake cycle disturbances, and possibly other factors related to the duration of the disease, act as cofactors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Priming and Human Memory Systems
Tulving, E., & Schacter, D. L. (1990) · Science · doi:10.1126/science.2296719 · Cited by 2,595
Complex visual hallucinations. Clinical and neurobiological insights
Manford, M. (1998) · Brain · doi:10.1093/brain/121.10.1819 · Cited by 680
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease
Krack, P. (1998) · Brain · doi:10.1093/brain/121.3.451 · Cited by 608
Downes, J. J., Roberts, A. C., Sahakian, B. J., Evenden, J. L., Morris, R. G., & Robbins, T. W. (1989) · Neuropsychologia · doi:10.1016/0028-3932(89)90128-0 · Cited by 527
Risk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 455
Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome
Teunisse, R. J., Zitman, F. G., Cruysberg, J. R. M., Hoefnagels, W. H. L., & Verbeek, A. L. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90869-7 · Cited by 438
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 348
Levodopa-induced psychosis: a kindling phenomenon
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.6.669 · Cited by 326
Visual Hallucinations Associated With Parkinson Disease
Sanchez-Ramos, J. R., Ortoll, R., & Paulson, G. W. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550120077019 · Cited by 324
Ballard, C., Holmes, C., McKeith, I., Neill, D., O’Brien, J., Cairns, N., Lantos, P., Perry, E., Ince, P., & Perry, R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1039 · Cited by 315
Bodis-Wollner, I. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90113-o · Cited by 296
The Hallucinations of Widowhood
Rees, W. D. (1971) · BMJ · doi:10.1136/bmj.4.5778.37 · Cited by 295
Mortality and hallucinations in nursing home patients with advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1995) · Neurology · doi:10.1212/wnl.45.4.669 · Cited by 287
Perry, E. K., & Perry, R. H. (1995) · Brain and Cognition · doi:10.1006/brcg.1995.1255 · Cited by 278
Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease
Albin, R. L., Minoshima, S., D'Amato, C. J., Frey, K. A., Kuhl, D. A., & Sima, A. A. F. (1996) · Neurology · doi:10.1212/wnl.47.2.462 · Cited by 241
Grimby, A. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03332.x · Cited by 237
Neuropsychological prediction of dementia in Parkinson's disease
Mahieux, F., Fenelon, G., Flahault, A., Manifacier, M.-J., Michelet, D., & Boller, F. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.178 · Cited by 219
Self-citationComella, C. L., Tanner, C. M., & Ristanovic, R. K. (1993) · Annals of Neurology · doi:10.1002/ana.410340514 · Cited by 211
Parkinson's disease: drug-induced psychiatric states.
Factor, S. A., Molho, E., Podskalny, G. D., & Brown, D. L. (1995) · PubMed · Cited by 203
Risk Factors for Depression in Parkinson Disease
Tandberg, E., Larsen, J. P., Aarsland, D., Laake, K., & Cummings, J. L. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170097020 · Cited by 202
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
Pillon, B., Dubois, B., Cusimano, G., Bonnet, A. M., Lhermitte, F., & Agid, Y. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.2.201 · Cited by 191
Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease
Pappert, E. J., Goetz, C. G., Niederman, F. G., Raman, R., & Leurgans, S. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<117::aid-mds1019>3.0.co;2-0 · Cited by 181
Auditory hallucinations in Parkinson's disease
Inzelberg, R., Kipervasser, S., & Korczyn, A. D. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.4.533 · Cited by 179
Goetz, C. G., Pappert, E. J., Blasucci, L. M., Stebbins, G. T., Ling, Z. D., Nora, M. V., & Carvey, P. M. (1998) · Neurology · doi:10.1212/wnl.50.2.515 · Cited by 170
Hallucinosis in idiopathic Parkinson's disease
Graham, J. M., Grunewald, R. A., & Sagar, H. J. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.4.434 · Cited by 167
Borght, T. V., Minoshima, S., Giordani, B., Foster, N. L., Frey, K. A., Berent, S., Albin, R. L., Koeppe, R. A., & Kuhl, D. E. (1997) · PubMed · Cited by 160
Early dopaminergic drug-induced hallucinations in parkinsonian patients
Goetz, C. G., Vogel, C., Tanner, C. M., & Stebbins, G. T. (1998) · Neurology · doi:10.1212/wnl.51.3.811 · Cited by 156
Poor visual discrimination and visual hallucinations in Parkinson's disease.
Diederich, N. J., Goetz, C. G., Raman, R., Pappert, E. J., Leurgans, S. E., & Pieri, V. (1998) · PubMed · Cited by 137
Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
Turner, T. H., Cookson, J., Wass, J. A. H., Drury, P. L., Price, P. A., & Besser, G. M. (1984) · BMJ · doi:10.1136/bmj.289.6452.1101 · Cited by 122
Cognitive Loss in Dementia With Lewy Bodies and Alzheimer Disease
Shimomura, T., Mori, E., Yamashita, H., Imamura, T., Hirono, N., Hashimoto, M., Tanimukai, S., Kazui, H., & Hanihara, T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.12.1547 · Cited by 114
A, T., Yang, K., Sung, J. H., & Frey, W. H. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.16 · Cited by 103
Psychotic Symptoms in Parkinson's Disease Patients with Dementia
Naimark, D. M. J., Jackson, E., Rockwell, E., & Jeste, D. V. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb00918.x · Cited by 97
The Management of the Levodopa Psychoses
Friedman, J. H. (1991) · Clinical Neuropharmacology · doi:10.1097/00002826-199108000-00001 · Cited by 94
Distorted color discrimination in ‘de nova’ parkinsonian patients
Büttner, T., Kuhn, W., Müller, T., Patzold, T., Heidbrink, K., & Przuntek, H. (1995) · Neurology · doi:10.1212/wnl.45.2.386 · Cited by 90
McShane, R. H., Gedling, K., Reading, M. C., McDonald, B., Esiri, M. M., & Hope, T. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.2.185 · Cited by 77
Mental disorders in Parkinson's disease after treatment with L-DOPA.
Rondot, P., de Recondo, J., Coignet, A., & Ziegler, M. (1984) · PubMed · Cited by 63
Managing Psychosis in Patients with Parkinson's Disease
Cummings, J. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401011 · Cited by 39
Late cognitive changes in Parkinson's disease with an emphasis on dementia.
Mohr, E., Mendis, T., & Jd, G. (1995) · PubMed · Cited by 36
Hallucinations in parkinson disease: Neuropsychological study
Meco, G., Bonifati, V., Cusimano, G., Fabrizio, E., & Vanacore, N. (1990) · Neurological Sciences · doi:10.1007/bf02335940 · Cited by 28
B�ttner, T., Kuhn, W., M�ller, T., Welter, F., Federlein, J., Heidbrink, K., & Przuntek, H. (1996) · Journal of Neural Transmission · doi:10.1007/bf01271204 · Cited by 22
A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis
Shergill, S. S., Walker, Z., & Katona, C. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.4.610 · Cited by 22
Cited by
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
Tomlinson, C. L., Stowe, R., Patel, S., Rick, C., Gray, R., & Clarke, C. E. (2010) · Movement Disorders · doi:10.1002/mds.23429 · Cited by 4,219
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Non-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Metadata
- Authors
- Fenelon, G.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-04-01
- Volume
- 123
- Issue
- 4
- Pages
- 733-745
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2589302021
- Cited by
- 1,037
- References
- 44
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.